STAQ Pharma, Inc.

FDA Class III Recall: STAQ Pharma's Ketamine Injection Faces Labeling Non-Compliance

STAQ Pharma, Inc. has initiated a nationwide Class III recall of Ketamine Hydrochloride Injection due to critical labeling errors concerning lot and expiration dates. This event signals a lapse in GMP, requiring immediate action from procurement and regulatory teams to assess supply chain integrity and ensure compliance with labeling standards for critical medications like Ketamine.